1H-1,2,4-Triazole, 1-methyl- → [4-(1-Methyl-1H-1,2,4-triazole-5-yl)-4-oxobutyl]carbamic acid 1,1-dimethylethyl ester

HRID 352145Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 352145
[CH3:1][C:2]([O:5][C:6](=[O:17])[NH:7][CH2:8][CH2:9][CH2:10][C:11](NCOC)=[O:12])([CH3:4])[CH3:3].[CH3:18][N:19]1[CH:23]=[N:22][CH:21]=[N:20]1>>[CH3:4][C:2]([O:5][C:6](=[O:17])[NH:7][CH2:8][CH2:9][CH2:10][C:11]([C:23]1[N:19]([CH3:18])[N:20]=[CH:21][N:22]=1)=[O:12])([CH3:1])[CH3:3]

Komponenten

3

Edukt 2

HCID 224591H-1,2,4-Triazole, 1-methyl-HCID 871517791,1-Dimethylethyl [4-(methoxymethylamino)-4-oxobutyl]-carbamate

Produkt 1

HCID 131724452[4-(1-Methyl-1H-1,2,4-triazole-5-yl)-4-oxobutyl]carbamic acid 1,1-dimethylethyl ester

Versuchsvorschrift

The subtitle compound was prepared according to the method of Example 43 step (b) using the product of Example 43 step (a) and 1-methyl-1H-1,2,4-triazole.

Quellen und Nachweise

ORD-Eintrag
ord-cc0f54a6688d41f2aad68822e207aedb
Quelldatensatz
uspto-grants-2004_06
Patentnummer
US06743939B2

Notizen zur Reaktion

Wird geladen…